_introduction-to-sglt2-inhibition-preview-1.jpg "Introduction to SGLT2 Inhibition from sgkt2 Video Screenshot Preview 1")
Gallery_introduction-to-sglt2-inhibition-preview-3.jpg "Introduction to SGLT2 Inhibition from sgkt2 Video Screenshot Preview 3")
Gallery_introduction-to-sglt2-inhibition-preview-hqdefault.jpg "Introduction to SGLT2 Inhibition from sgkt2 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 3 minutes 23 seconds
👁 View: 29.6K times
Play Audio:👁 View: 29.6K times
Description:
Boehringer Ingelheim
Boehringer Ingelheim
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_how-does-dapagliflozin-work-understanding-sglt2-inhibitors.webp "Zero To Finals")
_when-should-we-use-sglt2-inhibitors.webp "The France Foundation")
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.webp "Harvard Medical School Continuing Education")
_sglt2-inhibitors-mechanism-of-action.webp "Nonstop Neuron")
_best-practices-for-starting-sglt2-inhibitors-in-hfpef-treatment.webp "Medscape")
_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann.webp "Fresenius Medical Care North America")
⏲ 15 minutes 35 seconds 👁 896
_how-does-dapagliflozin-work-understanding-sglt2-inhibitors.jpg)
_when-should-we-use-sglt2-inhibitors.jpg)
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.jpg)
_sglt2-inhibitors-mechanism-of-action.jpg)
_best-practices-for-starting-sglt2-inhibitors-in-hfpef-treatment.jpg)
_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann.jpg)
![[+]](/images/menu.gif){kind=small}